EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, VRCA: Verrica Pharmaceuticals Inc

12 Nov 25 09:33
LAST:

3.738

CHANGE:
 0.08		OPEN:
3.610		HIGH:
3.800		ASK:
0.000		VOLUME:
4.6K
CHG(%):
2.12		PREV:
3.660		LOW:
3.550		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
12 Nov 253.6103.8003.5503.7384.6K
11 Nov 253.8703.8703.6203.66041.1K
10 Nov 253.5503.9903.5503.870117.4K
07 Nov 253.5103.5103.3603.46072.0K
06 Nov 253.4403.7283.4153.58048.7K
05 Nov 253.4403.5503.3503.45058.6K
04 Nov 253.4703.5703.2803.28070.8K
03 Nov 253.7003.8103.5103.56048.0K
31 Oct 253.4903.6783.4663.61033.0K
30 Oct 253.6303.6303.4303.53044.7K

COMPANY PROFILE

Name:Verrica Pharmaceuticals Inc
About:Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and sale of medications for the treatment of skin diseases in the United States. The company's product pipeline includes YCANTH (VP-102), which is in phase III clinical trial for the treatment of common warts; and has completed phase II clinical trial for treating external genital warts, as well as for molluscum contagiosum. It also develops VP-315, an oncolytic peptide-based injectable therapy that is in phase II clinical trial for the treatment of dermatology oncologic conditions, which include basal cell carcinoma; and VP-103, a cantharidin-based product candidate for treating plantar warts. The company has a collaboration and license agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize VP-315 for dermatological oncology indications, such as non-metastatic melanoma and non-metastatic merkel cell carcinoma. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.
Sector:Healthcare
Industry:Biotechnology
Address:44 West Gay Street, West Chester, PA, United States, 19380
Website:https://www.verrica.com
CUSIP:92511W108
CIK:0001660334
ISIN:US92511W1080
FIGI:BBG00L03BYB7
LEI:5493002L68H6THU5GW50

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-0.24 
Forward P/E:-6.03 
PEG Ratio:0.00 
Price to Sales:2.29 
Price to Book:-1.93 
Profit Margin:0.64 
Operating Margin:0.12 
Return on Assets:-0.52 
Return on Equity:7.77 
EPS Ratio:-7.74 
Revenue:14.7M 
Shares:9.45M 
Market Cap:35.3M 

TECHNICAL INDICATORS

MA5:3.623.1%
MA10:3.565.1%
MA20:3.760.5%
MA50:4.2112.6%
MA100:3.945.3%
MA200:2.2565.8%
STO9:38.03
STO14:38.03
RSI14:39.90 
WPR14:-54.24
MTM14:-0.30
ROC14:-0.08 
ATR:0.25 
Week High:3.996.8%
Week Low:3.3511.6%
Month High:4.5421.5%
Month Low:3.2865.8%
Year High:7.4098.0%
Year Low:0.38879.5%

RECENT SPLITS

Date Ratio
25 Jul 20251-10